Exclusive: ASML unveils EUV light source advance that could yield 50% more chips by 2030 | ReutersSkip to main content[Exclusive news, data and analytics for financial market professionalsLearn more aboutRefinitiv]A view shows the logo of Dutch computer chip equipment supplier ASML, in Veldhoven, Netherlands, January 29 2025. REUTERS/Piroschka van de Wouw [Purchase Licensing Rights, opens new tab]- Companies- Summary- United States, China aim to rival ASML amid export control talks- Power boost to 1,000W cu ...

Core Viewpoint - Dominion Energy forecasts annual profit below Wall Street expectations while increasing its five-year capital spending plan by nearly 30% to meet rising electricity demand [1] Group 1: Financial Forecasts - Dominion Energy expects fiscal 2026 operating earnings of $3.45 to $3.69 per share, with the midpoint below analysts' average estimate of $3.60 [1] - The company's fourth-quarter operating expenses rose nearly 11% to $3.33 billion compared to the previous year, impacting overall financial performance [1] - Dominion's adjusted profit for the quarter ended December 31 was 68 cents per share, slightly exceeding estimates of 67 cents [1] Group 2: Capital Expenditure Plans - Dominion plans to spend $64.7 billion on capital investments from 2026 through 2030, an increase from its prior budget of $50.1 billion through 2029 [1] - The utility has contracted nearly 48.5 gigawatts of data center capacity as of December, reflecting a 1.4 GW increase since September [1] Group 3: Market Context - U.S. utilities, including Dominion, are increasing capital expenditure budgets due to extreme weather conditions and rising demand for new power capacity from data centers, particularly those focused on artificial intelligence and cryptocurrency [1] - Dominion serves the world's largest data center market, which exceeds the combined capacity of the next five largest markets in the U.S. [1]

Banco BPM clears governance overhaul, opening door for bigger Credit Agricole role | ReutersSkip to main content[Exclusive news, data and analytics for financial market professionalsLearn more aboutRefinitiv]A Credit Agricole logo outside a bank office in Reze, near Nantes, February 3, 2026. REUTERS/Stephane Mahe [Purchase Licensing Rights, opens new tab]- Companies- Summary- CA's choice will shape fund shareholders' representation- CA could gain seats via current board's list, or file its own- Bank's share ...

Core Insights - Gossamer Bio's experimental drug for a serious lung and heart condition failed to meet the primary endpoint in a late-stage clinical trial [1] Company Summary - Gossamer Bio announced the failure of its experimental drug in a late-stage study, which is a significant setback for the company [1]

Dollar has lost some of its safe-haven status, ING report says | ReutersSkip to main content[Exclusive news, data and analytics for financial market professionalsLearn more aboutRefinitiv]A U.S. Dollar note is seen in this June 22, 2017 illustration photo. REUTERS/Thomas White/Illustration [Purchase Licensing Rights, opens new tab]LONDON, Feb 23 (Reuters) - The dollar has lost some, but not all, of its safe-haven value since 2024, ING said in note on Monday, adding however, that it saw no broad deterioratio ...

Gilead to acquire cancer therapy developer Arcellx for up to $7.8 billion | ReutersSkip to main content[Exclusive news, data and analytics for financial market professionalsLearn more aboutRefinitiv]Logos of Gilead at the company's booth at the 8th China International Import Expo (CIIE) in Shanghai, China, November 6, 2025.REUTERS/Maxim Shemetov [Purchase Licensing Rights, opens new tab]- Companies[Arcellx Inc]Follow[Gilead Sciences Inc]FollowFeb 23 (Reuters) - Gilead Sciences will pay as much as $7.8 billi ...

Investment Plan Overview - Enel plans to invest approximately $63 billion in total, with a significant portion allocated to power grids in Spain through its subsidiary Endesa [1][2] - The investment in Spanish power grids is projected to be around 5.5 billion euros ($6.5 billion), representing about 21% of the total grid investment [2] Historical Context - This new investment marks a substantial increase from the previous allocation of roughly 4 billion euros by Endesa for power grid investments [3] - The decision comes in the wake of a massive blackout in Spain and Portugal on April 28, which has intensified discussions regarding the necessity and returns of investments in the power network [2] Regulatory Environment - Spain's competition watchdog has set the expected financial return for power grid activities at 6.58%, which is lower than the over 7% return that Spanish power utilities, including Endesa, have advocated for [3]

Sign up here. Skip to main content Exclusive news, data and analytics for financial market professionalsLearn more aboutRefinitiv South Korea wins UK challenge to arbitration ruling in Samsung merger case February 23, 202612:11 PM UTCUpdated ago By Reuters LONDON, Feb 23 (Reuters) - South Korea on Monday partially won its challenge to an arbitration award in its long-running dispute with U.S. hedge fund Elliott over the 2015 merger of two Samsung affiliates. The South Korean government was ordered to pay El ...

Company Overview - Generate Biomedicines, a drug developer based in Somerville, Massachusetts, is targeting a valuation of up to $2.17 billion in its upcoming initial public offering (IPO) in the United States [1] - The company is backed by venture firm Flagship Pioneering and aims to raise up to $425 million by offering 25 million shares priced between $15 and $17 each [1] IPO Details - Generate Biomedicines plans to list on the Nasdaq under the symbol "GENB" [1] - The IPO comes as biotech offerings have seen a strong start this year, following a sluggish 2025, attributed to easing interest rates and increased capital inflows into the sector [1] Underwriters - The underwriters for the offering include Goldman Sachs, Morgan Stanley, Piper Sandler, Guggenheim Securities, and Cantor [1]

Skip to main content Exclusive news, data and analytics for financial market professionalsLearn more aboutRefinitiv Novo Nordisk slump wipes out last Wegovy-era gains after trial setback February 23, 202611:43 AM UTCUpdated ago By Reuters The logo of pharmaceutical company Novo Nordisk is displayed on a flag in front of its offices in Bagsvaerd, Copenhagen, Denmark, February 4, 2026. REUTERS/Tom Little Purchase Licensing Rights, opens new tab Feb 23 (Reuters) - Novo Nordisk (NOVOb.CO), opens new tab shares ...